New Italian Scheme Aims To Lower Parallel Import Prices
Medicines Agency Publishes First Parallel Trade Report
Once a major source of parallel exports because of its low drug prices, Italy is now taking steps to reduce medicine spending by targeting the burgeoning parallel import market.
